| Samrat Pharmachem Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530125 |
NSE Symbol : - |
P/E(TTM) : 54.15 |
|
ISIN Demat : INE103E01016 |
Div & Yield% : 0.16 |
EPS(TTM) : 11.70 |
|
Book Value(₹) : 210.35 |
Market Cap(₹Cr) : 195.78 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 80.82 | 82.68 | 61.67 | 79.74 | 57.48 | 69.18 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 80.82 | 82.68 | 61.67 | 79.74 | 57.48 | 69.18 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.59 | 0.30 | 0.42 | 0.30 | 0.36 | 0.03 |
| Total Income | 81.41 | 82.98 | 62.09 | 80.04 | 57.84 | 69.21 |
| Total Expenditure | 78.24 | 81.33 | 61.56 | 79.51 | 56.71 | 69.67 |
| PBIDT | 3.17 | 1.65 | 0.53 | 0.53 | 1.13 | -0.46 |
| Interest | 0.19 | 0.11 | 0.23 | 0.13 | 0.22 | 0.17 |
| PBDT | 2.98 | 1.55 | 0.30 | 0.40 | 0.91 | -0.63 |
| Depreciation | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Tax | 0.60 | -0.08 | 0.11 | 0.06 | 0.19 | 0.36 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.15 | 0.08 | -0.31 | 0.36 | -0.05 | -0.41 |
| Reported Profit After Tax | 2.07 | 1.40 | 0.34 | -0.19 | 0.61 | -0.74 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.07 | 1.40 | 0.34 | -0.19 | 0.61 | -0.74 |
| EPS (Unit Curr.) | 6.68 | 4.52 | 1.11 | -0.61 | 1.98 | -2.41 |
| EPS (Adj) (Unit Curr.) | 6.68 | 4.52 | 1.11 | -0.61 | 1.98 | -2.41 |
| Calculated EPS (Unit Curr.) | 6.68 | 4.52 | 1.11 | -0.61 | 1.98 | -2.41 |
| Calculated EPS (Adj) (Unit Curr.) | 6.68 | 4.52 | 1.11 | -0.61 | 1.98 | -2.41 |
| Calculated EPS (Ann.) (Unit Curr.) | 26.74 | 18.06 | 4.46 | -2.44 | 7.91 | -9.64 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 26.74 | 18.06 | 4.46 | -2.44 | 7.91 | -9.64 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 3.92 | 2.00 | 0.86 | 0.66 | 1.97 | -0.66 |
| PBDTM(%) | 3.69 | 1.87 | 0.49 | 0.50 | 1.58 | -0.91 |
| PATM(%) | 2.56 | 1.69 | 0.55 | -0.24 | 1.06 | -1.07 |